Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Shen

Showing results (851-860 of 1,611) with videos related to

Pageof 162
Sort By:
Therapeutic Advances in Medical Oncology|June 24, 2022
Molecular mechanisms underlying the resistance of BRAF V600E-mutant metastatic colorectal cancer to EGFR/BRAF inhibitorsTing Xu, Xicheng Wang, Zhenghang Wang, et al.
Frontiers in Surgery|May 1, 2023
Repair of fingertip defect with reverse digital artery island flap and repair of donor site with digital dorsal advancement flapJunwei Ma, Yunqi Ding, Lina Xu, et al.
Drug Design, Development and Therapy|July 9, 2024
Clinical Efficacy of Taxol Plus Platinum (TP) Chemotherapy Combined with Delayed Administration of PD-1 Inhibitors in Patients with Locally Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma: A Retrospective StudyLin Shen, Zixuan Chen, Zhi Zhang, et al.
The Lancet. Oncology|February 7, 2019
Challenges in anticancer drug R&D in ChinaShen Zhao, Cheng Lv, Jifang Gong, et al.
International Journal of Biological Sciences|July 18, 2022
DDX3 acts as a tumor suppressor in colorectal cancer as loss of DDX3 in advanced cancer promotes tumor progression by activating the MAPK pathwayLin Shen, Jing Zhang, Meng Xu, et al.
Journal of Translational Medicine|June 6, 2017
CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrestJiayuan Wang, Qingqing Li, Jiajia Yuan, et al.
Journal of Agricultural and Food Chemistry|July 11, 2017
SlMAPK1/2/3 and Antioxidant Enzymes Are Associated with H<sub>2</sub>O<sub>2</sub>-Induced Chilling Tolerance in Tomato PlantsLiu Wang, Ruirui Zhao, Yanyan Zheng, et al.
Contrast Media & Molecular Imaging|April 24, 2018
Clinical and Prognostic Value of PET/CT Imaging with Combination of <sup>68</sup>Ga-DOTATATE and <sup>18</sup>F-FDG in Gastroenteropancreatic Neuroendocrine NeoplasmsPanpan Zhang, Jiangyuan Yu, Jie Li, et al.
Cell Death & Disease|June 2, 2018
A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivoJianling Zou, Shuang Li, Zuhua Chen, et al.
Journal of Gastroenterology|February 23, 2015
Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapyJun Zhou, Zhi Peng, Yi Liu, et al.
Pageof 162

Showing results (851-860 of 1,611) with videos related to

Sort By:
Pageof 162
Therapeutic Advances in Medical Oncology|June 24, 2022
Molecular mechanisms underlying the resistance of BRAF V600E-mutant metastatic colorectal cancer to EGFR/BRAF inhibitorsTing Xu, Xicheng Wang, Zhenghang Wang, et al.
Frontiers in Surgery|May 1, 2023
Repair of fingertip defect with reverse digital artery island flap and repair of donor site with digital dorsal advancement flapJunwei Ma, Yunqi Ding, Lina Xu, et al.
Drug Design, Development and Therapy|July 9, 2024
Clinical Efficacy of Taxol Plus Platinum (TP) Chemotherapy Combined with Delayed Administration of PD-1 Inhibitors in Patients with Locally Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma: A Retrospective StudyLin Shen, Zixuan Chen, Zhi Zhang, et al.
The Lancet. Oncology|February 7, 2019
Challenges in anticancer drug R&D in ChinaShen Zhao, Cheng Lv, Jifang Gong, et al.
International Journal of Biological Sciences|July 18, 2022
DDX3 acts as a tumor suppressor in colorectal cancer as loss of DDX3 in advanced cancer promotes tumor progression by activating the MAPK pathwayLin Shen, Jing Zhang, Meng Xu, et al.
Journal of Translational Medicine|June 6, 2017
CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrestJiayuan Wang, Qingqing Li, Jiajia Yuan, et al.
Journal of Agricultural and Food Chemistry|July 11, 2017
SlMAPK1/2/3 and Antioxidant Enzymes Are Associated with H<sub>2</sub>O<sub>2</sub>-Induced Chilling Tolerance in Tomato PlantsLiu Wang, Ruirui Zhao, Yanyan Zheng, et al.
Contrast Media & Molecular Imaging|April 24, 2018
Clinical and Prognostic Value of PET/CT Imaging with Combination of <sup>68</sup>Ga-DOTATATE and <sup>18</sup>F-FDG in Gastroenteropancreatic Neuroendocrine NeoplasmsPanpan Zhang, Jiangyuan Yu, Jie Li, et al.
Cell Death & Disease|June 2, 2018
A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivoJianling Zou, Shuang Li, Zuhua Chen, et al.
Journal of Gastroenterology|February 23, 2015
Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapyJun Zhou, Zhi Peng, Yi Liu, et al.
Pageof 162